Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

Sajith Wickramasekara was just 24 when he made the cut for the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Today, Wickramasekara joins the ranks of unicorn founders as Benchling ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

SAN FRANCISCO, May 20, 2026 /PRNewswire/ -- Benchling and Baseten today announced Benchling Inference, giving biotech customers scalable, cost-effective GPU capacity to train and run scientific models ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run Benchling Biologics is the end-to-end platform for antibody R&D, giving teams the AI-ready ...

Last year, Benchling raised $200 million through a series E round to help expand its digital platform followed by a $100 million series F just over six months later ...

Life sciences-focused cloud startup Benchling has seen its business soar over the last few years due to the pandemic, and a renewed interest in biotech among investors. Now, just as it hits a ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...